![Prakash Gudsoorkar(@gudnephron) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1504936903191183370/GEktO8Xz_200x200.jpg)
Prakash Gudsoorkar
@gudnephron
Kidneydoc | @UCKidney | @RPANephrology EC Public Policy Fellow 2023 | Director OncoNephrology Program @UC_Health I Editorial Board @KidneyNews @akdhjounal
ID:2953251591
31-12-2014 15:32:05
3,8K Tweets
1,5K Followers
1,5K Following
![Vincent Rajkumar(@VincentRK) 's Twitter Profile Photo Vincent Rajkumar(@VincentRK) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1271563144381464576/MYis_acO_200x200.jpg)
Monoclonal Gammopathy of Undetermined Significance (MGUS).
Present in ~5% of all people age 50+
Therefore something all clinicians should know about. Brief summary.
#medtwitter ESH (Haematology)
1/
![Vincent Rajkumar (@VincentRK) on Twitter photo 2022-10-11 15:56:51 Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/](https://pbs.twimg.com/media/FezNfnoUAAAdsCF.jpg)
![Kenar Jhaveri(@kdjhaveri) 's Twitter Profile Photo Kenar Jhaveri(@kdjhaveri) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1508844884303794180/gWqT3WzF_200x200.jpg)
May 2024 ASN Kidney News kidneynews.org/view/journals/…
Predicting Cisplatin-Induced Kidney Injury Prakash Gudsoorkar American Society of Nephrology
![Kenar Jhaveri (@kdjhaveri) on Twitter photo 2024-05-07 12:49:11 May 2024 @KidneyNews kidneynews.org/view/journals/… Predicting Cisplatin-Induced Kidney Injury @gudnephron @ASNKidney May 2024 @KidneyNews kidneynews.org/view/journals/… Predicting Cisplatin-Induced Kidney Injury @gudnephron @ASNKidney](https://pbs.twimg.com/media/GM-jIn1WYAAOh2D.jpg)
![HofNorthwell Kidney(@HofstraKidney) 's Twitter Profile Photo HofNorthwell Kidney(@HofstraKidney) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1142824925989941248/RD0gdqTd_200x200.jpg)
Onco-Hypertension in Patients with Kidney Disease | American Journal of Nephrology Susana Hong Northwell Department of Medicine American J Nephrol karger.com/ajn/article/do…
![Kenar Jhaveri(@kdjhaveri) 's Twitter Profile Photo Kenar Jhaveri(@kdjhaveri) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1508844884303794180/gWqT3WzF_200x200.jpg)
Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology | Cardiorenal Medicine Rose Mary Attieh International Cardio-Oncology Society American Society of Onconephrology karger.com/crm/article/do…
![KatieOverV(@KatieKwonMD) 's Twitter Profile Photo KatieOverV(@KatieKwonMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1565346912206655488/HZgSM2bw_200x200.jpg)
Woot woot! My latest article for ASN Kidney News made the top of American Society of Nephrology’s daily email briefing! Full article here: kidneynews.org/view/journals/…
![KatieOverV (@KatieKwonMD) on Twitter photo 2024-04-24 12:49:28 Woot woot! My latest article for @KidneyNews made the top of @ASNKidney’s daily email briefing! Full article here: kidneynews.org/view/journals/… Woot woot! My latest article for @KidneyNews made the top of @ASNKidney’s daily email briefing! Full article here: kidneynews.org/view/journals/…](https://pbs.twimg.com/media/GL7ml7rXcAA-4QT.jpg)
![Nephrology Journal Club(@NephJC) 's Twitter Profile Photo Nephrology Journal Club(@NephJC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/662057138684952577/2ZnKmQ3p_200x200.png)
![Prakash Gudsoorkar(@gudnephron) 's Twitter Profile Photo Prakash Gudsoorkar(@gudnephron) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1504936903191183370/GEktO8Xz_200x200.jpg)
It was fun to guest edit this important issue on Liver Kidney Connection with Juan Carlos Q Velez Ochsner Nephrology and Geetha Maddukuri SLU Nephrons
Thanks for the support Charuhas V Thakar
National Kidney Foundation
AKDH
UC Kidney
UC College of Medicine
![JASN_News(@JASN_News) 's Twitter Profile Photo JASN_News(@JASN_News) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1359929276468850691/Wm_i6aye_200x200.png)
![Monarch Shah(@monarchshah08) 's Twitter Profile Photo Monarch Shah(@monarchshah08) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1282454424493928453/mYrLYfHO_200x200.jpg)
Apheresis trends in #kidney #transplantation poster at World Congress of Nephrology by UVA Nephrology team!
Jeanne Kamal Tushar Chopra
![Monarch Shah (@monarchshah08) on Twitter photo 2024-04-18 23:32:50 Apheresis trends in #kidney #transplantation poster at @ISNWCN by @UVANeph team! @jeanne_kamal @NephTushar Apheresis trends in #kidney #transplantation poster at @ISNWCN by @UVANeph team! @jeanne_kamal @NephTushar](https://pbs.twimg.com/media/GLfATljWIAAkZD8.jpg)
![JASN_News(@JASN_News) 's Twitter Profile Photo JASN_News(@JASN_News) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1359929276468850691/Wm_i6aye_200x200.png)
![Scott Isaacs(@scottisaacsmd) 's Twitter Profile Photo Scott Isaacs(@scottisaacsmd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1659541603378245632/tAStpDfR_200x200.jpg)
This meta-analysis examined the effectiveness and safety of #tirzepatide in treating overweight and obesity compared with other weight loss drugs and GLP-1 receptor agonists.
onlinelibrary.wiley.com/doi/epdf/10.10…
![Scott Isaacs (@scottisaacsmd) on Twitter photo 2024-04-17 10:23:00 This meta-analysis examined the effectiveness and safety of #tirzepatide in treating overweight and obesity compared with other weight loss drugs and GLP-1 receptor agonists. onlinelibrary.wiley.com/doi/epdf/10.10… This meta-analysis examined the effectiveness and safety of #tirzepatide in treating overweight and obesity compared with other weight loss drugs and GLP-1 receptor agonists. onlinelibrary.wiley.com/doi/epdf/10.10…](https://pbs.twimg.com/media/GLI4YYdWAAE4Wdp.png)
![Brendon Neuen(@brendonneuen) 's Twitter Profile Photo Brendon Neuen(@brendonneuen) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1769816320529379328/Hg1jkPLk_200x200.jpg)
As Swapnil Hiremath @[email protected] points out, our task at implementation is going to become even more critical after FLOW
We need to reimagine, develop & refine a new framework that addresses urgency of optimising GDMT in ppl at high cardio-renal risk
Full text in Circulation ahajournals.org/doi/10.1161/CI…
![Brendon Neuen (@brendonneuen) on Twitter photo 2024-04-16 20:41:08 As @hswapnil points out, our task at implementation is going to become even more critical after FLOW We need to reimagine, develop & refine a new framework that addresses urgency of optimising GDMT in ppl at high cardio-renal risk Full text in @CircAHA ahajournals.org/doi/10.1161/CI… As @hswapnil points out, our task at implementation is going to become even more critical after FLOW We need to reimagine, develop & refine a new framework that addresses urgency of optimising GDMT in ppl at high cardio-renal risk Full text in @CircAHA ahajournals.org/doi/10.1161/CI…](https://pbs.twimg.com/media/GLUDrVlXgAAhX2C.jpg)
![Sabine Karam(@SabineKaram6) 's Twitter Profile Photo Sabine Karam(@SabineKaram6) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1501361214932365320/aqV3DhRB_200x200.jpg)
![Brendon Neuen(@brendonneuen) 's Twitter Profile Photo Brendon Neuen(@brendonneuen) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1769816320529379328/Hg1jkPLk_200x200.jpg)
How can we prioritise accelerated therapeutic implementation of the 'four pillars' of GDMT for diabetes & CKD?
-RASi
-SGLT2i
-ns-MRA
-GLP-1RA
Muthu Vaduganathan Katherine Tuttle & I outline what an 'accelerated, risk-based approach' might look like
Circulation ahajournals.org/doi/10.1161/CI…
![Brendon Neuen (@brendonneuen) on Twitter photo 2024-04-15 21:05:24 How can we prioritise accelerated therapeutic implementation of the 'four pillars' of GDMT for diabetes & CKD? -RASi -SGLT2i -ns-MRA -GLP-1RA @mvaduganathan @KatherineTuttl8 & I outline what an 'accelerated, risk-based approach' might look like @CircAHA ahajournals.org/doi/10.1161/CI… How can we prioritise accelerated therapeutic implementation of the 'four pillars' of GDMT for diabetes & CKD? -RASi -SGLT2i -ns-MRA -GLP-1RA @mvaduganathan @KatherineTuttl8 & I outline what an 'accelerated, risk-based approach' might look like @CircAHA ahajournals.org/doi/10.1161/CI…](https://pbs.twimg.com/media/GLPADXSbUAAN-Ts.jpg)
![HEPATOLOGY Journal(@HEP_Journal) 's Twitter Profile Photo HEPATOLOGY Journal(@HEP_Journal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1618651912013758466/x45ejiVD_200x200.jpg)
REVIEW
Controversies regarding albumin therapy in cirrhosis
#JonelTrebicka Guadalupe GarciaTsao
#LiverTwitter
tinyurl.com/2j2burcu
![HEPATOLOGY Journal (@HEP_Journal) on Twitter photo 2024-04-14 16:03:00 REVIEW Controversies regarding albumin therapy in cirrhosis #JonelTrebicka @ggarciatsao #LiverTwitter tinyurl.com/2j2burcu REVIEW Controversies regarding albumin therapy in cirrhosis #JonelTrebicka @ggarciatsao #LiverTwitter tinyurl.com/2j2burcu](https://pbs.twimg.com/media/GKHaGXDWkAA0Dvj.jpg)
![NEJM(@NEJM) 's Twitter Profile Photo NEJM(@NEJM) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/893483773362393088/US3DliFV_200x200.jpg)